Advisors Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $302K | Sell |
|
|||||
|
2025
Q2 | $255K | Sell |
|
|||||
|
2025
Q1 | $234K | Sell |
|
|||||
|
2024
Q4 | $304K | Sell |
|
|||||
|
2024
Q3 | $454K | Buy |
|
|||||
|
2024
Q2 | $504K | Sell |
|
|||||
|
2024
Q1 | $645K | Buy |
|
|||||
|
2023
Q4 | $416K | Sell |
|
|||||
|
2023
Q3 | $328K | Buy |
|
|||||
|
2023
Q2 | $321K | Sell |
|
|||||
|
2023
Q1 | $534K | Sell |
|
|||||
|
2022
Q4 | $484K | Sell |
|
|||||
|
2022
Q3 | $1.47M | Sell |
|
|||||
|
2022
Q2 | $1.45M | Sell |
|
|||||
|
2022
Q1 | $1.74M | Sell |
|
|||||
|
2021
Q4 | $2.8M | Sell |
|
|||||
|
2021
Q3 | $4.23M | Buy |
|
|||||
|
2021
Q2 | $5.52M | Buy |
|
|||||
|
2021
Q1 | $3.51M | Buy |
|
|||||
|
2020
Q4 | $2.57M | Buy |
|
|||||
|
2020
Q3 | $296K | Buy |
|
|||||
|
2020
Q2 | $139K | Buy |
|